Rapid Micro Biosystems (NASDAQ:RPID) Coverage Initiated at KeyCorp

Research analysts at KeyCorp started coverage on shares of Rapid Micro Biosystems (NASDAQ:RPID) in a research note issued to investors on Wednesday,Briefing.com Automated Import reports. The firm set an “overweight” rating and a $8.00 price target on the stock. KeyCorp’s price objective would suggest a potential upside of 198.51% from the stock’s current price.

Rapid Micro Biosystems Price Performance

RPID opened at $2.68 on Wednesday. The company’s 50 day simple moving average is $1.36 and its two-hundred day simple moving average is $1.08. The firm has a market capitalization of $115.32 million, a price-to-earnings ratio of -2.39 and a beta of 1.26. Rapid Micro Biosystems has a 1-year low of $0.58 and a 1-year high of $3.15.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.